Royal London Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.7M | Sell |
51,028
-39,119
| -43% | -$25.1M | 0.06% | 266 |
|
|
2025
Q4 | $61M | Sell |
90,147
-6
| -0% | -$4.09K | 0.13% | 148 |
|
|
2025
Q3 | $57.6M | Sell |
90,153
-826
| -0.9% | -$501K | 0.12% | 156 |
|
|
2025
Q2 | $48.8M | Sell |
90,979
-930
| -1% | -$445K | 0.11% | 163 |
|
|
2025
Q1 | $38.6M | Buy |
91,909
+3,755
| +4% | +$1.63M | 0.09% | 199 |
|
|
2024
Q4 | $36.4M | Sell |
88,154
-14,918
| -14% | -$6.54M | 0.09% | 185 |
|
|
2024
Q3 | $52.1M | Buy |
103,072
+2,189
| +2% | +$1.06M | 0.13% | 144 |
|
|
2024
Q2 | $49.2M | Sell |
100,883
-12,119
| -11% | -$6.08M | 0.13% | 138 |
|
|
2024
Q1 | $61M | Buy |
113,002
+28,452
| +34% | +$15.5M | 0.15% | 122 |
|
|
2023
Q4 | $46.9M | Buy |
84,550
+340
| +0.4% | +$160K | 0.13% | 134 |
|
|
2023
Q3 | $36.8M | Buy |
84,210
+8,195
| +11% | +$4.09M | 0.12% | 147 |
|
|
2023
Q2 | $38.2M | Buy |
76,015
+20,082
| +36% | +$9.62M | 0.12% | 138 |
|
|
2023
Q1 | $28M | Buy |
55,933
+1,830
| +3% | +$876K | 0.11% | 153 |
|
|
2022
Q4 | $22.1M | Buy |
54,103
+1,049
| +2% | +$407K | 0.1% | 180 |
|
|
2022
Q3 | $17.3M | Sell |
53,054
-4,689
| -8% | -$1.72M | 0.09% | 196 |
|
|
2022
Q2 | $20.3M | Sell |
57,743
-308
| -0.5% | -$126K | 0.09% | 182 |
|
|
2022
Q1 | $31.8M | Sell |
58,051
-18,316
| -24% | -$9.63M | 0.12% | 146 |
|
|
2021
Q4 | $50.3M | Sell |
76,367
-9,152
| -11% | -$5.75M | 0.19% | 102 |
|
|
2021
Q3 | $53.2M | Sell |
85,519
-16,489
| -16% | -$11.1M | 0.22% | 95 |
|
|
2021
Q2 | $64.4M | Sell |
102,008
-2,810
| -3% | -$1.55M | 0.26% | 79 |
|
|
2021
Q1 | $51.3M | Buy |
104,818
+4,017
| +4% | +$2.01M | 0.24% | 95 |
|
|
2020
Q4 | $50.3M | Buy |
100,801
+67,184
| +200% | +$30.1M | 0.26% | 81 |
|
|
2020
Q3 | $12.9M | Hold |
33,617
| – | – | 0.08% | 213 |
|
|
2020
Q2 | $11M | Sell |
33,617
-1,521
| -4% | -$440K | 0.08% | 227 |
|
|
2020
Q1 | $8.47M | Sell |
35,138
-184
| -0.5% | -$48K | 0.07% | 249 |
|
|
2019
Q4 | $9.24M | Buy |
35,322
+1,805
| +5% | +$476K | 0.06% | 280 |
|
|
2019
Q3 | $9.12M | Buy |
33,517
+2,306
| +7% | +$642K | 0.07% | 278 |
|
|
2019
Q2 | $8.59M | Sell |
31,211
-5,758
| -16% | -$1.42M | 0.08% | 242 |
|
|
2019
Q1 | $8.27M | Hold |
36,969
| – | – | 0.07% | 297 |
|
|
2018
Q4 | $6.87M | Buy |
36,969
+2,089
| +6% | +$428K | 0.06% | 312 |
|
|
2018
Q3 | $8.71M | Sell |
34,880
-772
| -2% | -$187K | 0.09% | 226 |
|
|
2018
Q2 | $7.77M | Buy |
+35,652
| New | +$7.35M | 0.08% | 270 |
|
Other funds holding IDXX
VCM
VPM
Royal London Asset Management's IDXX Position: Q1 2026 in Review
Royal London Asset Management reduced its Idexx Laboratories (IDXX) stake by 43% in Q1 2026, selling an estimated $25.1M and leaving 51,028 shares worth $28.7M. The position accounts for 0.06% of the portfolio, ranked #266.
Royal London Asset Management first reported a position in IDXX in Q2 2018 and has held it in 32 quarters since. The position peaked at $64.4M in Q2 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Royal London Asset Management held 51,028 shares of Idexx Laboratories worth $28.7M as of Q1 2026.
- Royal London Asset Management sold 39,119 Idexx Laboratories shares in Q1 2026, an estimated $25.1M.
- Idexx Laboratories made up 0.06% of Royal London Asset Management's portfolio in Q1 2026, its #266 holding.
- Royal London Asset Management first reported a position in Idexx Laboratories in Q2 2018 and has held it in 32 quarters since.
- Royal London Asset Management's Idexx Laboratories position peaked at $64.4M in Q2 2021.
- 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.